Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child

Pediatric Infectious Disease Journal

Volumn 25, Issue 3, 2006, Pages 275-276

  Schmitz, Thomas ^a   Kleinkauf, Niels ^a   Klempa, Boris ^a   Ringe, Hannelore ^a   Varnholt, Verena ^a   Grosch Wörner, Ilse ^a  

^a Children's Hospital   (Germany)

Author keywords

Human immunodeficiency virus drug resistance; Mother to child transmission; Nevirapine; Nonnucleoside reverse transcription antagonists; Transmission of primary resistance

Indexed keywords

ABACAVIR; COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; MALE; PHYLOGENETIC TREE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SEROTYPE; VERTICAL TRANSMISSION; VIRUS MUTATION; VIRUS TRANSMISSION;

EID: 33644886363     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000202142.34502.5e     Document Type: Article

References (10)

1. Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002; 288:181-188.
2. Niehues T, Walter H, Honeff G, Wahn V, Schmidt B. Selective vertical transmission of HIV: lamivudine resistant maternal clone undetectable by conventional resistance testing. AIDS. 1999;13:2482.
3. Johnson VA, Petropoulos CJ, Woods CR, et al. Vertical transmission of multidrug resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1 infected child. J Infect Dis. 2001;183:1688-1693.
4. Nicastri E, Sarmati L, d'Ettorre G, et al. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. J Med Virol. 2003;69:1-6.
5. Barbour J, Hecht F, Wrin T, et al. Persistence of primary drug resistance among recently HIV-1 infected adults. AIDS. 2004;18:1683-1689.
6. Brenner B, Routy JP, Quan Y, et al and Co-Investigators of the Quebec Primary Infection Study. Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS. 2004;18:1653-1660.
7. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385-394.
8. Lyall EGH, Walter MDS, Tudor-Williams G. Baby cocktail: a palatable four drug combo for HIV infected infants. Paper presented at: 4th International Congress on Drug Therapy of HIV Infection, Glasgow, 2001, United Kingdom.
9. Nahmias AJ, Clark WS, Kourtis AP, et al. Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group. J Infect Dis. 1998;178:680-685.
10. Renjifo B, Gilbert P, Chaplin B, et al and HIV Study Group. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS. 2004;18:1629-1636.